162 related articles for article (PubMed ID: 32664187)
1. Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients.
Chua-On D; Proungvitaya T; Tummanatsakun D; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sangkhamanon S; Proungvitaya S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664187
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Tummanatsakun D; Araki N; Proungvitaya S
Cancer Genomics Proteomics; 2022; 19(1):35-49. PubMed ID: 34949658
[TBL] [Abstract][Full Text] [Related]
3. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
Zheng A; Zhang L; Song X; Wang Y; Wei M; Jin F
BMC Cancer; 2019 May; 19(1):451. PubMed ID: 31088422
[TBL] [Abstract][Full Text] [Related]
6. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
[TBL] [Abstract][Full Text] [Related]
7. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
11. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.
Aung TM; Ciin MN; Silsirivanit A; Jusakul A; Lert-Itthiporn W; Proungvitaya T; Roytrakul S; Proungvitaya S
Front Public Health; 2022; 10():836985. PubMed ID: 35392474
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome.
Subimerb C; Wongkham C; Khuntikeo N; Leelayuwat C; McGrath MS; Wongkham S
Asian Pac J Cancer Prev; 2014; 15(10):4217-24. PubMed ID: 24935374
[TBL] [Abstract][Full Text] [Related]
15. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
[TBL] [Abstract][Full Text] [Related]
16. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
Molecules; 2021 May; 26(9):. PubMed ID: 34066878
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.
Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U
Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379
[TBL] [Abstract][Full Text] [Related]
19. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
Front Public Health; 2022; 10():835914. PubMed ID: 35991009
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.
Deng Y; Chen Y
Oncol Res Treat; 2017; 40(3):128-132. PubMed ID: 28118648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
